Jul 27, 2023 / 10:00AM GMT
Presentation
Jul 27, 2023 / 10:00AM GMT
=====================
Corporate Participants
=====================
* Andrew S. Plump
Takeda Pharmaceutical Company Limited - President of Research & Development and Representative Director
* Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director
* Christopher David O'Reilly
Takeda Pharmaceutical Company Limited - Global Head of IR & Global Finance
* Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Representative Director
* Julie Kim
Takeda Pharmaceutical Company Limited - President of the U.S. Business Unit & U.S. Country Head
* Ramona Sequeira
Takeda Pharmaceutical Company Limited - President of Global Portfolio Division
=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research
Takeda Pharmaceutical Co Ltd
(WBO:TKD)
€
29.91
+0.15 (+0.5%)
Market Cap: 47.49 Bil
Enterprise Value: 70.54 Bil
PE Ratio: 0
PB Ratio: 1.17
GF Score: 19/100 Q1 2024 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript
Jul 27, 2023 / 10:00AM GMT
Release Date Price:
€28.44
(+1.75%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot